Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Allergan Successfully Completes ZELTIQ® Aesthetics Acquisition
Saturday, April 29, 2017Allergan plc a leading global biopharmaceutical company today announced it has successfully completed the acquisition of ZELTIQ Aesthetics Inc a medical technology company behind a proprietary controlledcooling fat reducing treatment CoolSculpting Al...
Savara Announces Closing Of Merger With Mast Therapeutics
Friday, April 28, 2017Savara Inc a clinicalstage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or lifethreatening rare respiratory diseases today announced the closing of its previously an...
BridgeBio Pharma Launches Eidos Therapeutics to Develop Targeted Therapy for Fatal Heart Disease
Friday, April 28, 2017BridgeBio Pharma announced the launch of Eidos Therapeutics a biopharmaceutical company developing a novel smallmolecule treatment for transthyretin TTR amyloidosis BridgeBio has committed million and seasoned RD executives to advance Eidos lead com...
The Medicines Company and Alnylam Pharmaceuticals Announce Agreement with FDA on Phase III Clinical Program for Inclisiran
Thursday, April 27, 2017The Medicines Company and Alnylam Pharmaceuticals Inctoday announced that The Medicines Company has agreed with the US Food and Drug Administration FDA on plans for the Phase III clinical program for inclisiran which is designed to support the submis...
Heptares Collaboration With AstraZeneca Yields New Insights to Advance Drug Discovery in Pain, Cancer and Inflammation
Thursday, April 27, 2017Heptares Therapeutics Heptares the whollyowned subsidiary of Sosei Group Corporation TSE Mothers Index describes new insights for drug discovery from the first resolved highresolution Xray crystal structures of the ProteaseActivated Receptor PAR in...
DelMar Pharmaceuticals Collaborates with Duke University to Explore VAL-083
Wednesday, April 26, 2017DelMar Pharmaceuticals Inc a biopharmaceutical company focused on the development and commercialization of new cancer therapies today announced that it has entered into a threeyear collaboration with Duke University to evaluate VAL the Companys platf...
AstraZeneca's lung cancer drug Tagrisso receives full approval in the EU
Wednesday, April 26, 2017AstraZeneca announced that the European Commission EC has granted full marketing authorisation for Tagrisso osimertinib mg and mg oncedaily tablets for the treatment of adult patients with locallyadvanced or metastatic epidermal growth factor recepto...
Akebia Therapeutics and Otsuka Pharmaceutical Expand Relationship with Collaboration to Develop and Commercialise Vadadustat
Wednesday, April 26, 2017Akebia Therapeutics Inc and Otsuka Pharmaceutical Co Ltd announced that they have expanded their collaboration for vadadustat by entering into a collaboration and license agreement for Europe China and other territories Vadadustat is an oral hypoxiai...
Servier and CTI BioPharma Expand License and Collaboration Agreement
Tuesday, April 25, 2017Servier and CTI BioPharma Corp jointly announced that they agreed to expand their existing license and development collaboration agreement for PIXUVRI pixantrone Under this expanded agreement Servier will have rights to PIXUVRI in all markets except...
Orexigen Therapeutics Announces New Drug Submission for Contrave© in Canada
Tuesday, April 25, 2017Orexigen Therapeutics Inc a biopharmaceutical company helping to improve the health and lives of patients struggling with weight loss today announced that Health Canada has completed its screening phase and accepted for review a New Drug Submission f...
